NFE2L2 and early-onset autosomal dominant Alzheimer disease: Additionally, the neuroprotective effects of MG were observed in various neurodegenerative disorders, including Parkinson’s Disease, Alzheimer’s Disease, Huntington’s Disease, and Amyotrophic Lateral Sclerosis, where once again, Nrf2 activation played a central role [10].